© 1995 American Heart Association, Inc.
Articles |
Determinants of Antiarrhythmic Drug Action
Electrostatic and Hydrophobic Components of Block of the Human Cardiac hKv1.5 Channel
From the Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn.
Abstract The molecular basis of antiarrhythmic drug action is
still poorly understood. We recently reported that block of the human
cardiac hKv1.5 channel by quinidine displayed similarity with internal
quaternary ammonium block of squid and Shaker potassium
channels. To gain further insight into the molecular determinants of
the affinity and the stereoselectivity of antiarrhythmic drug action,
we studied the effects of quinine (a diastereomer of quinidine),
clofilium (a quaternary ammonium class III agent), and
tetrapentylammonium (TPeA, a biophysical reference probe for the
internal quaternary ammonium binding site). For all compounds, block
was voltage dependent, with a steep increase over the voltage range of
channel opening and a superimposed weaker voltage dependence at more
positive potentials. The latter electrostatic component was similar for
all drugs, consistent with a binding reaction sensing 
20%
of the transmembrane electrical field. Clofilium and TPeA displayed a
higher apparent affinity (0.15 and 0.28 µmol/L, respectively), and
quinine displayed a lower one (21 µmol/L) compared with quinidine
(6.2 µmol/L). Block development upon depolarization was time
dependent for clofilium and TPeA but slow compared with quinidine. A
time-dependent component was difficult to resolve for quinine, but the
time course of deactivating tail currents was slower than in the
control condition. The resulting crossover phenomenon was also observed
for the quaternary drugs. Compared with TPeA alone, the combined
application of quinine and TPeA resulted in a reduced current that
decayed slower, consistent with competition. When a bimolecular
model for open-channel block was used, the apparent association rate
constants for these drugs were found to be similar [range, 4.5 to 7.7
(µmol/L)-1 · s-1]. The apparent
dissociation rate constants for clofilium (1.9 s-1) and
TPeA (3.6 s-1) were smaller compared with quinidine (34
s-1), whereas that for quinine was faster (
125
s-1). This large range in dissociation rate constants
could explain the differences between these drugs both in kinetics and
affinity. The results are consistent with a general model in
which these agents act as cationic open-channel blockers but with an
affinity largely determined by the intrinsic stability of the
drug-receptor complex. Hydrophobic interactions are most likely
involved in this stabilization of binding.
Key Words: K+ channels • antiarrhythmia agents • quaternary ammonium • quinidine • clofilium
This article has been cited by other articles:
 |
|
 |
|
  S. C. dos Santos, S. Tenreiro, M. Palma, J. Becker, and I. Sa-Correia Transcriptomic Profiling of the Saccharomyces cerevisiae Response to Quinine Reveals a Glucose Limitation Response Attributable to Drug-Induced Inhibition of Glucose Uptake Antimicrob. Agents Chemother., December 1, 2009; 53(12): 5213 - 5223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Schumacher, D. P. McEwen, L. Zhang, K. L. Arendt, K. M. Van Genderen, and J. R. Martens Antiarrhythmic Drug-Induced Internalization of the Atrial-Specific K+ Channel Kv1.5 Circ. Res., June 19, 2009; 104(12): 1390 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Decher, P. Kumar, T. Gonzalez, B. Pirard, and M. C. Sanguinetti Binding Site of a Novel Kv1.5 Blocker: A "Foot in the Door" against Atrial Fibrillation Mol. Pharmacol., October 1, 2006; 70(4): 1204 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Decher, P. Kumar, T. Gonzalez, V. Renigunta, and M. C. Sanguinetti Structural Basis for Competition between Drug Binding and Kv{beta}1.3 Accessory Subunit-Induced N-Type Inactivation of Kv1.5 Channels Mol. Pharmacol., October 1, 2005; 68(4): 995 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Choi, J.-A. Park, K.-R. Kim, G.-I. Lee, Y.-T. Lee, H. Choe, S.-H. Ko, M.-H. Kim, Y.-H. Seo, and Y.-G. Kwak Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents Am J Physiol Cell Physiol, August 1, 2005; 289(2): C425 - C436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Garcia-Ferreiro, D. Kerschensteiner, F. Major, F. Monje, W. Stuhmer, and L. A. Pardo Mechanism of Block of hEag1 K+ Channels by Imipramine and Astemizole J. Gen. Physiol., September 27, 2004; 124(4): 301 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Vargas, S. Tenreiro, M. C. Teixeira, A. R. Fernandes, and I. Sa-Correia Saccharomyces cerevisiae Multidrug Transporter Qdr2p (Yil121wp): Localization and Function as a Quinidine Resistance Determinant Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2531 - 2537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Decher, B. Pirard, F. Bundis, S. Peukert, K.-H. Baringhaus, A. E. Busch, K. Steinmeyer, and M. C. Sanguinetti Molecular Basis for Kv1.5 Channel Block: CONSERVATION OF DRUG BINDING SITES AMONG VOLTAGE-GATED K+ CHANNELS J. Biol. Chem., January 2, 2004; 279(1): 394 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wang, M. J Morales, Y.-J. Qu, G. C L Bett, H. C Strauss, and R. L Rasmusson Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect J. Physiol., January 15, 2003; 546(2): 387 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Caballero, I. Moreno, T. Gonzalez, C. Valenzuela, J. Tamargo, and E. Delpon Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5) Cardiovasc Res, October 1, 2002; 56(1): 104 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Godreau, R. Vranckx, and S. N. Hatem Mechanisms of Action of Antiarrhythmic Agent Bertosamil on hKv1.5 Channels and Outward Potassium Current in Human Atrial Myocytes J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 612 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Perchenet, L. Hilfiger, J. Mizrahi, and O. Clement-Chomienne Effects of Anorexinogen Agents on Cloned Voltage-Gated K+ Channel hKv1.5 J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1108 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Iftinca, G. J. Waldron, C. R. Triggle, and W. C. Cole State-Dependent Block of Rabbit Vascular Smooth Muscle Delayed Rectifier and Kv1.5 Channels by Inhibitors of Cytochrome P450-Dependent Enzymes J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 718 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Brock, C. Mathes, and W. F. Gilly Selective Open-Channel Block of Shaker (Kv1) Potassium Channels by S-Nitrosodithiothreitol (Sndtt) J. Gen. Physiol., July 1, 2001; 118(1): 113 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, A. Y. Xiao, T. Ichinose, and S. P. Yu Effects of Tetraethylammonium Analogs on Apoptosis and Membrane Currents in Cultured Cortical Neurons J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 524 - 530. [Abstract] [Full Text]
|
|
|
|
|
|
B. H. Choi, J.-S. Choi, S.-W. Jeong, S. J. Hahn, S. H. Yoon, Y.-H. Jo, and M.-S. Kim Direct Block by Bisindolylmaleimide of Rat Kv1.5 Expressed in Chinese Hamster Ovary Cells J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 634 - 640. [Abstract] [Full Text]
|
|
|
|
|
|
L. Yue, J. L. Feng, Z. Wang, and S. Nattel Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes Cardiovasc Res, April 1, 2000; 46(1): 151 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Delpon, R. Caballero, C. Valenzuela, M. Longobardo, D. Snyders, and J. Tamargo Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5) Cardiovasc Res, May 1, 1999; 42(2): 510 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Cogolludo, F. Perez-Vizcaino, and J. Tamargo Antagonism by Class I Antiarrhythmic Drugs of Levcromakalim-Induced Relaxation in Isolated Rat Aorta J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 81 - 86. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Lu, L. Yue, Z. Wang, and S. Nattel Effects of the Diuretic Agent Indapamide on Na+, Transient Outward, and Delayed Rectifier Currents in Canine Atrial Myocytes Circ. Res., July 27, 1998; 83(2): 158 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Longobardo, E. Delpón, R. Caballero, J. Tamargo, and C. Valenzuela Structural Determinants of Potency and Stereoselective Block of hKv1.5 Channels Induced by Local Anesthetics Mol. Pharmacol., July 1, 1998; 54(1): 162 - 169. [Abstract] [Full Text]
|
|
|
|
|
|
V. N. Uebele, S. K. England, D. J. Gallagher, D. J. Snyders, P. B. Bennett, and M. M. Tamkun Distinct domains of the voltage-gated K+ channel Kvbeta 1.3 beta -subunit affect voltage-dependent gating Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1485 - C1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S.P. Chen and D. Fedida On the Mechanism by which 4-Aminopyridine Occludes Quinidine Block of the Cardiac K+ Channel, hKv1.5 J. Gen. Physiol., April 1, 1998; 111(4): 539 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Franqueza, M. Longobardo, J. Vicente, E. Delpon, M. M. Tamkun, J. Tamargo, D. J. Snyders, and C. Valenzuela Molecular Determinants of Stereoselective Bupivacaine Block of hKv1.5 Channels Circ. Res., December 19, 1997; 81(6): 1053 - 1064. [Abstract] [Full Text]
|
|
|
|
|
|
X. Zhang, J. W. Anderson, and D. Fedida J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1247 - 1256. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Valenzuela, E. Delpon, L. Franqueza, P. Gay, O. Perez, J. Tamargo, and D. J. Snyders Class III Antiarrhythmic Effects of Zatebradine: Time-, State-, Use-, and Voltage-Dependent Block of hKv1.5 Channels Circulation, August 1, 1996; 94(3): 562 - 570. [Abstract] [Full Text]
|
|
|
|
|
|
S. W. Yeola, T. C. Rich, V. N. Uebele, M. M. Tamkun, and D. J. Snyders Molecular Analysis of a Binding Site for Quinidine in a Human Cardiac Delayed Rectifier K+ Channel : Role of S6 in Antiarrhythmic Drug Binding Circ. Res., June 1, 1996; 78(6): 1105 - 1114. [Abstract] [Full Text]
|
|
|
|
|
|
V. N. Uebele, S. K. England, A. Chaudhary, M. M. Tamkun, and D. J. Snyders Functional Differences in Kv1.5 Currents Expressed in Mammalian Cell Lines Are Due to the Presence of Endogenous Kvbeta2.1 Subunits J. Biol. Chem., February 2, 1996; 271(5): 2406 - 2412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Choi, J.-S. Choi, D.-J. Rhie, S. H. Yoon, D. S. Min, Y.-H. Jo, M.-S. Kim, and S. J. Hahn Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1461 - C1468. [Abstract] [Full Text] [PDF]
|
|